*Correspondence: Theerthankar Das, [email protected] Present address: Theerthankar Das, Microbiology and Infectious Diseases, School of Medicine, Ingham Institute, Western Sydney University, NSW, Australia These authors share last authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Physiological Reviews , 95(3), 857-900
Variants like GLP1R rs6923761 and FTO rs9939609 may influence metabolic inflammation severity and response patterns, but genetics are one piece of a much larger clinical picture that includes disease activity, antibody status, and functional capacity
These coordinated adaptations enable therapeutic weight reduction
LifeMD announces lower cash-pay prices for GLP-1 medications, enhancing accessibility for patients through its virtual care platform